BUB1B and neoplasm: In contrast, another study shows that overexpression of BubR1 was associated with a less advanced tumor stage, but patients with overexpression of BubR1 showed shorter recurrence-free survival than those without it, making BubR1 a promising prognostic marker in patients with OSCC [64].